Browse EV MemProt Atlas
Supporting publications (n)

Number of publications supporting the inclusion of this protein in EV MemProt Atlas.

EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
CD40LP29965CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form (sCD40L)]Cancer-related genesCandidate cardiovascular disease genesCD markers1B-cell lymphomaDiabetes mellitusDiffuse large B-cell lymphomaAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
CD79BP40259B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b)Cancer-related genesCD markersDisease related genes1Autoimmune diseaseDiffuse large B-cell lymphomaFollicular lymphomaClinical-translation mediationFusion and delivery mediationImmune mediation10.50
CN37P095432',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)Disease related genesEnzymesHuman disease related genesImmune mediation10.50
COHA1Q9UMD9Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)]Cancer-related genesDisease related genesHuman disease related genes1Adhesion and uptake mediationImmune mediationReceptor-signaling mediation10.50
COQ7Q99807NADPH-dependent 3-demethoxyubiquinone 3-hydroxylase, mitochondrial (EC 1.14.13.253) (3-demethoxyubiquinone 3-hydroxylase (NADH)) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)Disease related genesEnzymesHuman disease related genesImmune mediationMetabolism mediation10.50
CX3C1P49238CX3C chemokine receptor 1 (C-X3-C CKR-1) (CX3CR1) (Beta chemokine receptor-like 1) (CMK-BRL-1) (CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28)Disease related genesG-protein coupled receptorsHuman disease related genes7Clinical-translation mediationFusion and delivery mediationImmune mediation10.50
CXCR2P25025C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD antigen CD182)Cancer-related genesCD markersDisease related genes7AsthmaChronic obstructive pulmonary diseaseCystic fibrosisAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
DAG1Q14118Dystroglycan 1 (Dystroglycan) (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)]Disease related genesHuman disease related genesPlasma proteins1Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
DHDDSQ86SQ9Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Cis-prenyltransferase subunit hCIT) (Epididymis tissue protein Li 189m)Disease related genesEnzymesEssential proteinsClinical-translation mediationMetabolism mediation10.50
DP13AQ9UKG1DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)Disease related genesHuman disease related genesPredicted intracellular proteinsFusion and delivery mediationImmune mediationMetabolism mediation10.50
DVL1O14640Segment polarity protein dishevelled homolog DVL-1 (Dishevelled-1) (DSH homolog 1)Disease related genesHuman disease related genesPlasma proteinsAdhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation10.50
E41L3Q9Y2J2Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) (Erythrocyte membrane protein band 4.1-like 3) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]Plasma proteinsPredicted intracellular proteinsPredicted membrane proteinsFusion and delivery mediation10.50
EFR3AQ14156Protein EFR3 homolog A (Protein EFR3-like)Disease related genesPredicted intracellular proteinsMetabolism mediation10.50
EGFRP00533Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)Cancer-related genesDisease related genesEnzymes1Angina pectorisBrain cancerBreast cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
EGLNP17813Endoglin (CD antigen CD105)Cancer-related genesCandidate cardiovascular disease genesCD markers1AngiosarcomaBrain cancerBreast cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
EPHA3P29320Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1)Cancer-related genesDisease related genesEnzymes1Acute myeloid leukaemiaBrain cancerMalignant haematopoietic neoplasmAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediation10.50
EVI2AP22794Protein EVI2A (Ecotropic viral integration site 2A protein homolog) (EVI-2A)Predicted membrane proteins1Other mediation10.50
EVI2BP34910Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361)CD markersPredicted membrane proteins1Immune mediation10.50
FCG2AP12318Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32)CD markersFDA approved drug targetsHuman disease related genes1Chronic kidney diseaseLupus erythematosusThrombocytopeniaClinical-translation mediationFusion and delivery mediationImmune mediation10.50
FGD1P98174FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3)Disease related genesHuman disease related genesPlasma proteinsReceptor-signaling mediation10.50
FLNCQ14315Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin)Disease related genesHuman disease related genesPlasma proteinsAdhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation10.50
FLRT3Q9NZU0Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3)Disease related genesHuman disease related genesPotential drug targets1Adhesion and uptake mediationReceptor-signaling mediation10.50
GBRA1P14867Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1) (GABAAR subunit alpha-1)Disease related genesFDA approved drug targetsHuman disease related genes4Acute respiratory distress syndromeAnxiety disorderChronic insomniaClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
GBRA3P34903Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3) (GABAAR subunit alpha-3)FDA approved drug targetsPredicted membrane proteinsTransporters4Anxiety disorderIndeterminate colitisIntentional self-harmClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50
GBRG1Q8N1C3Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1) (GABAAR subunit gamma-1)FDA approved drug targetsPredicted membrane proteins4Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation10.50

276-300 of 792 proteins

Page